Kangmei Pharma | 600518 - Assets


Kangmei Pharma reported CNY13.07B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Akebia Therapeutics USD 342.13M 7.53M Sep/2026
Alaunos Therapeutics USD 1.52M 367K Jun/2026
Avita Medical AUD 47.78M 8.62M Jun/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Dianthus Therapeutics USD 1.28B 62.98M Sep/2026
Genomma Lab Internacional MXN 25.32B 1.12B Sep/2026
Hypermarcas BRL 26.32B 969.84M Sep/2026
Ionis Pharmaceuticals USD 2.91B 81.91M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Jiangsu Hengrui CNY 76.72B 5.95B Sep/2026
Kangmei Pharma CNY 13.07B 239.31M Jun/2026
Moderna USD 13.47B 2.51B Sep/2026
Organon & Co USD 13.4B 223M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Sh Fosun Pharma CNY 126.79B 1.36B Sep/2026
Tectonic Therapeutic USD 237.03M 9.54M Jun/2026
Viatris USD 34.68B 362M Sep/2026
Wuxi Apptec CNY 125.16B 8.89B Sep/2026
Xeris Pharmaceuticals USD 423.22M 11.31M Sep/2026
Zz Pientze Pharmaceu CNY 17.71B 799.05M Sep/2026